HealthcareServices

m-RNA Synthesis Service Global Forecast: Market to Scale Up to $7.89 Billion by 2030 at 9.6% CAGR

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the m-rna synthesis service market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the m-RNA Synthesis Service Market in 2026, and what figure is it projected to hit by 2030?

The m-rna synthesis service market has experienced substantial expansion in recent years. It is forecast to grow from $4.99 billion in 2025 to $5.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This historical growth can be linked to the acceleration of vaccine research programs, a rise in funding for genetic research, the expansion of contract research services, increased utilization of mrna in academic studies, and advancements in transcription efficiency technologies.

The m-rna synthesis service market size is anticipated to experience substantial growth over the coming years, with projections indicating an expansion to $7.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This projected growth during the forecast period is primarily driven by an expanding pipeline of mRNA-based therapeutics, the increasing need for personalized medicine solutions, the broadening scope of gene therapy research, a growing reliance on outsourcing synthesis services, and a rise in regulatory approvals for mRNA products. Significant trends identified for the forecast period encompass a surging demand for custom mRNA constructs, the increasing adoption of GMP-grade mRNA production, the expanding utilization of scalable in vitro transcription platforms, the proliferation of rapid turnaround synthesis services, and an intensified focus on achieving high-purity mRNA outputs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24611&type=smp

Which Drivers Are Affecting Market Participation In The m-RNA Synthesis Service Market?

The future expansion of the mRNA synthesis service market is anticipated to be driven by the growing emphasis on personalized medicine. This medical strategy involves customizing treatments and healthcare choices based on a person’s unique genetic profile, lifestyle, and surroundings. The rise of personalized medicine is attributed to breakthroughs in genomic sequencing, which facilitate more accurate identification of genetic variations associated with diseases and treatment effectiveness. mRNA synthesis services contribute to this focus by enabling the swift and accurate creation of mRNA-based therapies specifically designed for an individual’s genetic makeup, leading to more targeted and effective interventions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from 6 in 2022. Among these, seven were cancer drugs, and three were designed for other diseases and conditions. Consequently, the heightened attention on personalized medicine is fueling the growth of the mRNA synthesis service market.

What Segment Categories Are Covered In The m-RNA Synthesis Service Market?

The m-rna synthesis service market covered in this report is segmented –

1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis

2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics

3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines

2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support

What Trends Are Driving The Growth Trajectory Of The m-RNA Synthesis Service Market?

Key players within the mRNA synthesis service market are concentrating on creating novel solutions, including advancements in RNA polymerase, aimed at enhancing the efficiency, yield, and safety of mRNA synthesis. These RNA polymerase innovations involve crafting sophisticated enzymes designed to optimize the transcription process, reduce undesirable outcomes like double-stranded RNA formation, and elevate the overall quality of mRNA for use in vaccines and therapeutics. A notable example occurred in March 2025, when Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to improve the efficiency and scalability of mRNA synthesis. This particular enzyme boasts enhanced processivity and high-fidelity transcription, allowing it to generate extended and more stable mRNA strands while minimizing error rates. Its strong performance within in vitro transcription systems reduces impurities and significantly increases overall yield, thereby providing a reliable and scalable solution for firms involved in mRNA-based drug development. Such an innovation holds particular significance in the expanding domain of personalized medicine, given that precise and efficient mRNA synthesis is critical there.

Which Key Players Are Driving Competition In The m-RNA Synthesis Service Market?

Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The m-RNA Synthesis Service Market?

North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized m-RNA Synthesis Service Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24611&type=smp

Browse Through More Reports Similar to the Global m-RNA Synthesis Service Market 2026, By The Business Research Company

Microrna Market Report 2026

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Rna Targeting Small Molecules Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795